1. Introduction
===============

Asthma is one of the most common chronic inflammatory diseases among children, and characterized by recurrent seizures.^\[[@R1],[@R2]\]^ Its symptoms contain cough, wheezing, shortness of breath and chest tightness.^\[[@R3]\]^ The occurrence of asthma severely threatens children\'s health, lives, study and activities as well as their growths and developments. The disease also generates heavy burden to family and society. Reportedly, asthma is a complex multifactorial disease, involving genetic and environmental triggers.^\[[@R4]\]^ Environment factors, such as tobacco smoke, vitamin D insufficiency and high-lipid diet, are all risk factors for asthma in children.^\[[@R5],[@R6]\]^ Exposing to these risk factors could result in asthma, but only in a small part of children. Therefore, genetic factors may play a key role in asthma etiology. Scholars pay attentions to the disease heredity, especially genetic polymorphisms.^\[[@R7]--[@R9]\]^ However, up to now, the pathology and etiology of asthma in children remain unclear.

A disintegrin and metalloprotease 33 (ADAM33) is a transmembrane metalloproteinase which belongs to the subgroup of zinc-dependent metalloproteinase super-family.^\[[@R10],[@R11]\]^ It is encoded by *ADAM33* gene which is located on chromosome 20p13, and usually expressed in bronchial smooth muscle cells and lung fibroblasts.^\[[@R12],[@R13]\]^*ADAM33* has been proved to participate in cell adhesion, cell fusion, cell signaling, and cell-cell interaction, which suggests that it may play an important role in pulmonary defenses.^\[[@R14]\]^ All the time, as a vital candidate gene, *ADAM33* is widely studied in asthma among various populations.^\[[@R15]--[@R17]\]^*ADAM33* gene covers many single nucleotide polymorphisms (SNPs). Until now, scholars have achieved inconsistent conclusions on the role of *ADAM33* polymorphisms in childhood asthma in different races.

In this study, we selected 3 polymorphisms (rs678881, rs2280089, rs2853209) in *ADAM33* to explore their associations with childhood asthma risk in Chinese Han population, which are studied rarely in asthma but widely in others diseases. Linkage disequilibrium among these polymorphisms was analyzed, and haplotype distributions were calculated to determine their association with asthma occurrence in children.

2. Materials and methods
========================

2.1. The case and control groups
--------------------------------

In this case-control study, 96 asthma children and 86 healthy children were selected. All subjects were Chinese Han people from the same region and had no blood relation between each other. This study was approved by the Research Ethics Committee of Xingtai People\'s Hospital and all subjects' guardians were informed of the whole study process. Written informed consents were signed by the participants' parents before blood extraction.

Patients in the case group were diagnosed based on their clinical symptoms and through pathological examinations. Healthy controls were from the physical examination center of the hospital during the same period. The control group was frequency-matched with the case group in age and sex.

2.2. DNA extraction
-------------------

2 ml peripheral venous blood from every participant was extracted into blood collection tube with EDTA anticoagulant, and then stored in --80°C freezer. Genomic DNA was extracted following the method of conventional chloroform/isoamyl alcohol extraction and then stored at --20°C for standby application.

2.3. Genotyping of *ADAM33* polymorphisms
-----------------------------------------

The genotyping of *ADAM33* polymorphisms was conducted through polymerase chain reaction-direct sequencing (PCR-DS). PCR primers were acquired from published articles^\[[@R18]--[@R20]\]^ and synthesized by Shanghai Sangon Biotech Co., Ltd. Primer sequences were shown in Table [1](#T1){ref-type="table"}. PCR system was a mixture of 25 μl, including 1 μl DNA template, 12.5 μl PCR Master Mix, each 0.5 μl of forward and reverse primers and ddH~2~O added to 25 μl. PCR program was as follows: pre-denaturation at 95°C for 3 minutes, followed by 45 cycles of denaturation at 94°C for 30 seconds, annealing at 60°C for 45 seconds, extension at 72°C for 30 seconds, and a final extension at 72°C for 7 minutes. The quality and concentration of PCR products were detected through 1.0% agarose gel electrophoresis (AGE) and NanoDrop 2000c instrument.
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The primer sequences of *ADAM33* polymorphisms.
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Eligible PCR products were sequenced in Shanghai Sangon Biotech Co., Ltd to determine the genotypes of *ADAM33* polymorphisms in all subjects.

2.4. Statistical analysis
-------------------------

The genotype distributions of *ADAM33* polymorphisms in the control group were tested for their conformity to Hardy-Weinberg equilibrium (HWE). Frequency differences in genotypes, alleles, and haplotypes were compared adopting chi-square test between the case and control groups. Odds ratio (OR) with 95% confidence interval (95%CI) was calculated to express the relative risk of childhood asthma. Data analyses were conducted utilizing PASW Statistics 18.0 software. *P* \< .05 was considered as the significant threshold. Linkage disequilibrium (LD) and the role of haplotypes in childhood asthma were also analyzed.

3. Results
==========

3.1. Detailed clinical information on all subjects
--------------------------------------------------

In the present study, a total of 182 subjects were selected, consisting of 96 cases and 86 controls. The case group included 57 boys and 39 girls between 3 and 12 years old, with a ratio of boys to girls at 1.46: 1. The control group consisted of 48 boys and 38 girls with age ranging between 4 and 14 years old, and the percentage of boys in the controls was near 56%. Therefore, difference in sex ratio between 2 groups was not significant (*P* \> .05). Similarly, there was no significant difference in age between the case and control groups (*P* \> .05).

3.2. Genotype and allele distributions of *ADAM33* polymorphisms in the case and control groups
-----------------------------------------------------------------------------------------------

Genotype distributions of *ADAM33* rs678881, rs2280089, and rs2853209 polymorphisms in the control group were all consistent with HWE (*P* \> .05, Table [2](#T2){ref-type="table"}), indicating that our study population came from a Mendelian population and possessed fine representativeness.
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The genotype frequency comparison of *ADAM33* polymorphisms between 2 study groups.
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When compared with GG genotype, GC genotype of rs678881 polymorphism showed obviously higher frequency in cases than in controls (*P* = .03) and its carriers faced higher risk of childhood asthma than GG carriers (OR = 2.03, 95%CI = 1.05--3.91). However, all of the genotypes and alleles of *ADAM33* rs2280089 and rs2853209 polymorphisms had no significantly different frequency between the case and control group, indicating they held no significant association with the susceptibility of asthma in children (Table [2](#T2){ref-type="table"}).

3.3. Haplotype analysis of *ADAM33* polymorphisms in childhood asthma
---------------------------------------------------------------------

LD between *ADAM33* rs678881, rs2280089, and rs2853209 polymorphisms was detected by Haploview. As shown in Table [3](#T3){ref-type="table"}, strong LD existed between them and 4 haplotypes were constructed, namely GGA, GGT, CGT, and GAT. Their percentages were 56.25%, 5.73%, 23.96%, and 14.06% in the case group and 55.23%, 20.35%, 16.28%, and 8.14% in the control group. Compared with GGA, GGT haplotype had significantly higher frequency in the control group than in the case group, indicating it could significantly decreased the susceptibility to asthma in children (OR = 0.28, 95%CI = 0.13--0.57).
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The haplotype analysis of *ADAM33* 3 polymorphisms.
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4. Discussion
=============

In the present study, three polymorphisms in *ADAM33* gene were detected for their association with asthma susceptibility in children. Among them, rs2280089 and rs2853209 showed no significant correlation with asthma in Chinese Han children. In the study performed by Miyake et al, similar results were reached for these two polymorphisms in Europeans.^\[[@R21]\]^ Furthermore, Liang et al conducted a meta-analysis to explore the influence of *ADAM33* polymorphisms on asthma, and found that rs2538209 had no significant association with childhood asthma.^\[[@R22]\]^ Meanwhile, in our study, rs678881 was obviously correlated with increased susceptibility to childhood asthma, a similar finding to that in a previous study performed by Xue et al in Chinese adults.^\[[@R18]\]^

Therefore, *ADAM33* rs2280089 and rs2853209 polymorphisms possessed no independent influence on asthma risk among people at any age, including children, according to relevant researches. But referring to rs678881, due to the scarceness of related researches on Chinese population, its role in childhood asthma need to be further studied. Our study showed strong LD among these 3 polymorphisms, so their haplotypes were analyzed for the first time. Accordingly, haplotype GGT significantly associated with the decreased risk of childhood asthma, playing a protective role against childhood asthma.

ADAM, or metalloprotease disintegrin cysteine-rich (MDC), constitutes a glycoprotein family on membrane surface and covers multiple functional domains.^\[[@R23]\]^ It is consisted of approximately 800 amino acid and contains a number of conservative structural domains. In ADAM protein, there are signal peptide, regulatory region, metalloproteinase, disintegrin, cysteine-rich, endothelial growth factor and transmembrane domains, and intracellular glycoprotein domain from N to C terminal. The characteristics of ADAM domains include the interactions of cell-cell and cell-matrix mediated by a disintegrin domain, and ADAM participates in various signal transduction pathways through integrating a cysteine-rich domain into cell adhesion and a endothelial growth factor domain.^\[[@R24]\]^ Studies prove that the increased activity of ADAM proteolytic enzyme is involved in inflammatory airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD).^\[[@R25],[@R26]\]^

ADAM33 is a member of ADAM family and expressed in airway smooth muscle cells and lung fibroblasts. Consequently, ADAM33 not only plays a role in lung defense but also participates in airway vascular remodeling, airway inflammation and obstruction, and the reduction of lung function.^\[[@R27]\]^ Chen et al concluded that *ADAM33* polymorphisms might be involved in the development of mite-sensitized persistent allergic rhinitis in a Chinese population.^\[[@R28]\]^ Uh et al found that *ADAM33* rs628977G\>A polymorphism was correlated with idiopathic pulmonary fibrosis (IPF) risk and significantly decreased the disease susceptibility.^\[[@R29]\]^ Seven SNPs in *ADAM33* have been associated with COPD risk in a Chinese Mongolian population.^\[[@R30]\]^ In addition, some inflammatory diseases are affected by *ADAM33* polymorphisms as well, such as systemic lupus erythematosus and psoriasis. The role of *ADAM33* in asthma has been explored in previous studies and several SNPs have been proposed as susceptible factors for asthma. But due to differences in allele distribution for *ADAM33* polymoprhisms in different races, their functional mechanism in childhood asthma is still not completely illustrated.

In conclusion, *ADAM33* rs678881 polymorphism significantly increases the risk of childhood asthma in Chinese Han population, but not rs2280089 or rs2853209. Furthermore, strong LD exists among our focused three polymorphisms and GGT haplotype functions as a protective factor against childhood asthma. However, some disadvantages may affect the veracity of final results, such as small sample size, neglecting potential influences of environmental factors on the disease, and sole nationality of enrolled population. Therefore, well-designed further study with large enough sample size should be conducted to verify our findings and to explore the mechanism of *ADAM33* polymorphisms affecting childhood asthma in the future.
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